przewaquinone d has been researched along with gsk-2816126 in 2 studies
| Studies (przewaquinone d) | Trials (przewaquinone d) | Recent Studies (post-2010) (przewaquinone d) | Studies (gsk-2816126) | Trials (gsk-2816126) | Recent Studies (post-2010) (gsk-2816126) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 98 | 1 | 96 |
| Protein | Taxonomy | przewaquinone d (IC50) | gsk-2816126 (IC50) |
|---|---|---|---|
| Polycomb protein EED | Homo sapiens (human) | 0.016 | |
| Polycomb protein SUZ12 | Homo sapiens (human) | 0.016 | |
| Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | 0.035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, BJ; Chae, CH; Cho, H; Choi, G; Kim, HY; Lee, JY; Park, WK; Ryu, SY; Woo, J | 1 |
| Bhattacharya, D; Mukherjee, A; Talukdar, A | 1 |
2 other study(ies) available for przewaquinone d and gsk-2816126
| Article | Year |
|---|---|
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Molecular Conformation; Polycomb Repressive Complex 2; Structure-Activity Relationship | 2014 |
Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues.
Topics: Animals; Binding Sites; Cell Line, Tumor; Clinical Trials as Topic; Enzyme Inhibitors; Humans; Protein Binding; Protein-Arginine N-Methyltransferases; S-Adenosylmethionine | 2022 |